Smoking is considered a probable risk factor for ALS, but it’s not a direct cause in the way smoking causes lung cancer. A large meta-analysis of 32 studies found that smokers have about a 12% higher risk of developing ALS compared to people who have never smoked. Current smokers face a steeper increase, around 28%. That’s a real but modest bump in risk for a disease that remains rare overall, affecting roughly 2 out of every 100,000 people per year.
What the Evidence Actually Shows
The strongest evidence comes from a systematic review that pooled data from 28 case-control studies and four cohort studies. After adjusting for other factors, the odds of developing ALS were 12% higher among people who had ever smoked. When researchers looked only at people who were still actively smoking, the risk jumped to 28% higher than never-smokers.
A separate pooled analysis of five large prospective cohorts found a clear trend tied to cumulative smoking exposure. People who had smoked the equivalent of 1 to 20 pack-years had a 31% higher risk of ALS. Those in the 21 to 35 pack-year range had a 71% higher risk. Interestingly, the risk at the heaviest level (more than 35 pack-years) was 43% higher, not the highest category. The overall trend was still statistically significant, but the pattern wasn’t perfectly linear, which is one reason scientists describe smoking as a “probable” rather than “definitive” risk factor.
There’s another wrinkle: when researchers excluded never-smokers and looked only at people who had smoked at some point, the relationship between smoking intensity and ALS risk largely disappeared. This suggests the biggest difference is between ever having smoked and never having smoked at all, rather than a straightforward “more cigarettes equals more risk” equation.
How Smoking May Damage Motor Neurons
ALS destroys motor neurons, the nerve cells that control voluntary muscle movement. Cigarette smoke contains thousands of chemicals, and several of them can plausibly harm these cells through overlapping pathways.
The most studied mechanism is oxidative stress. Your cells constantly produce reactive molecules called free radicals as a byproduct of normal energy production. Normally, your body’s antioxidant defenses keep them in check. Tobacco smoke floods the body with additional free radicals, tipping the balance. When that happens, the excess radicals damage the fatty membranes surrounding neurons, degrade proteins, and corrupt DNA. Over time, this triggers inflammation and can cause cells to self-destruct.
This kind of damage also promotes abnormal protein clumping inside nerve cells, a hallmark of several neurodegenerative diseases including ALS. Formaldehyde, a known neurotoxin present in cigarette smoke, has been independently linked to ALS risk in occupational studies. Heavy metals like lead and cadmium, also found in tobacco smoke, can accumulate in the nervous system and compound the oxidative damage.
Smoking and ALS Prognosis
For people already diagnosed with ALS, smoking history appears to influence how quickly the disease progresses. A population-based study in China found that current smokers with 20 or more pack-years of exposure had a median survival of about 64 months, compared to roughly 81 months for current smokers with lighter histories. That’s a difference of more than 17 months.
Heavy smoking was also linked to faster functional decline. Patients with 20 or more pack-years lost physical abilities at a significantly faster rate, as measured by the standard scale doctors use to track ALS progression. Simply having smoked at some point, though, did not show a significant survival difference on its own. The intensity of the habit mattered more than the fact of having smoked.
Why Scientists Call It “Probable”
The ALS Association describes smoking as a probable risk factor, and that careful language reflects genuine uncertainty. There are a few reasons the science hasn’t fully closed the case.
First, ALS is rare enough that even large studies struggle to gather enough cases to detect small effects with confidence. Second, the dose-response relationship is inconsistent. A clear, linear increase in risk with more smoking would be more convincing, but the data shows a plateau or even a slight dip at the highest exposure levels. Third, unlike lung cancer, where the mechanism connecting smoke to DNA mutations in lung tissue is well mapped, the chain of events from cigarette smoke to motor neuron death is harder to trace in living humans.
That said, the overall pattern across dozens of studies points in the same direction. Smokers develop ALS more often than non-smokers, the association holds up after adjusting for age, sex, and other variables, and there are plausible biological reasons for it. Most researchers treat smoking as one piece of a larger puzzle of environmental exposures that can, in combination with genetic susceptibility, push someone toward the disease.
How Smoking Compares to Other ALS Risk Factors
ALS has no single dominant cause for most patients. About 5 to 10% of cases are familial, linked to inherited gene mutations. The remaining 90 to 95% are classified as sporadic, meaning they arise without a clear family history. For these cases, researchers believe the disease results from a combination of genetic vulnerability and environmental triggers accumulated over a lifetime.
Other environmental exposures studied alongside smoking include heavy metals, pesticides, head trauma, and intense physical activity. Among modifiable lifestyle factors, smoking has the most consistent body of evidence linking it to ALS risk. It is also the only one widely described as a probable risk factor by major ALS research organizations. That doesn’t mean it’s the strongest contributor in any individual case, but it is the one you have the most control over.